Xing Yang Selected Research

Adenocarcinoma

11/2023	Development of a 18F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer.
1/2019	The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma.
9/2017	64Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing Yang Research Topics

Disease

48	Neoplasms (Cancer) 05/2024 - 08/2012
19	Inflammation (Inflammations) 05/2024 - 03/2004
18	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 02/2012
16	Infections 03/2024 - 12/2014
7	ST Elevation Myocardial Infarction 04/2024 - 01/2014
7	Hypoxia (Hypoxemia) 04/2023 - 01/2018
7	Stroke (Strokes) 04/2023 - 01/2017
6	Myocardial Infarction 04/2024 - 04/2021
6	AIDS-Related Complex (ARC) 01/2023 - 03/2016
6	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 02/2012
5	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2015
4	Cicatrix (Scar) 05/2024 - 01/2021
4	Diverticulum 05/2024 - 01/2021
4	Glioma (Gliomas) 01/2024 - 02/2017
4	Cognitive Dysfunction 01/2024 - 01/2019
4	Osteoarthritis 11/2023 - 01/2022
4	Pain (Aches) 11/2023 - 01/2020
4	Peripheral Nervous System Diseases (PNS Diseases) 05/2023 - 01/2019
4	Breast Neoplasms (Breast Cancer) 03/2023 - 02/2012
4	Carcinoma (Carcinomatosis) 01/2023 - 06/2006
4	Nasopharyngeal Carcinoma 11/2022 - 01/2015
3	Adenocarcinoma 11/2023 - 09/2017
3	Non-alcoholic Fatty Liver Disease 05/2023 - 01/2022
3	Thrombosis (Thrombus) 01/2023 - 04/2021
3	Lymphatic Metastasis 11/2022 - 01/2020
3	COVID-19 01/2022 - 11/2020
3	Ischemia 01/2020 - 01/2019
3	Obesity 11/2016 - 11/2010
2	Liver Neoplasms (Liver Cancer) 04/2024 - 11/2022
2	Heart Diseases (Heart Disease) 04/2024 - 02/2023
2	Fibrosis (Cirrhosis) 03/2024 - 08/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2022
2	Wounds and Injuries (Trauma) 12/2023 - 01/2023
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2023 - 11/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 09/2015
2	Adenomyosis 10/2023 - 02/2016
2	Hyperalgesia 04/2023 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 01/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2023 - 01/2023
2	African Swine Fever 02/2023 - 01/2023
2	Parasitic Diseases (Parasitic Disease) 01/2023 - 06/2022
2	Ischemic Stroke 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2015
11	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2013
10	AntigensIBA 09/2023 - 01/2016
9	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2024 - 09/2013
8	LigandsIBA 05/2024 - 08/2016
6	Urea (Carbamide)FDA LinkGeneric 01/2023 - 01/2016
6	Carbonic Anhydrase IXIBA 11/2022 - 10/2015
6	EnzymesIBA 01/2022 - 10/2003
5	TitaniumIBA 12/2023 - 03/2016
5	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2017
5	CytokinesIBA 03/2022 - 11/2011
4	Radioisotopes (Radionuclides)IBA 05/2024 - 10/2015
4	Photosensitizing Agents (Photosensitizers)IBA 03/2024 - 01/2020
4	16S Ribosomal RNAIBA 12/2023 - 01/2023
4	Peptides (Polypeptides)IBA 11/2023 - 10/2021
4	oxalyldiaminopropionic acidIBA 01/2023 - 01/2022
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2024 - 11/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2015
3	HydrogelsIBA 01/2024 - 01/2023
3	AntioxidantsIBA 01/2024 - 05/2016
3	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2019
3	AcidsIBA 12/2023 - 01/2016
3	LipopolysaccharidesIBA 01/2023 - 01/2015
3	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023 - 01/2022
3	Caspase 3 (Caspase-3)IBA 01/2022 - 11/2016
3	InterferonsIBA 01/2021 - 12/2014
2	Immunoconjugates (Immunoconjugate)IBA 05/2024 - 01/2023
2	enfortumab vedotinIBA 05/2024 - 01/2023
2	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2015
2	pevonedistatIBA 01/2024 - 01/2022
2	SilicatesIBA 11/2023 - 03/2016
2	Contrast MediaIBA 11/2023 - 05/2018
2	Glutathione (Reduced Glutathione)IBA 11/2023 - 01/2023
2	Granzymes (Granzyme)IBA 11/2023 - 01/2022
2	AndrogensIBA 11/2023 - 07/2009
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2023 - 01/2023
2	Hyaluronic Acid (Hyaluronan)IBA 03/2023 - 06/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2023
2	Biotin (Vitamin H)FDA Link 01/2023 - 10/2021
2	Tryptophan (L-Tryptophan)FDA Link 01/2023 - 01/2023
2	ProdrugsIBA 01/2023 - 01/2020
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 03/2004
2	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2022 - 12/2021
2	ProteomeIBA 01/2022 - 01/2021
2	Glutamic Acid (Glutamate)FDA Link 10/2021 - 09/2017

Therapy/Procedure

37	Therapeutics 05/2024 - 09/2005
10	Drug Therapy (Chemotherapy) 04/2023 - 09/2015
5	Percutaneous Coronary Intervention 04/2024 - 01/2014
5	Stents 04/2022 - 04/2021
4	Cesarean Section (Caesarean Section) 05/2024 - 01/2021
4	Immunotherapy 12/2023 - 01/2022
3	Microspheres (Microsphere) 01/2024 - 01/2022
3	Injections 01/2024 - 01/2022
3	Precision Medicine 11/2023 - 01/2020
3	Lasers (Laser) 04/2023 - 01/2020
3	Radiotherapy 01/2022 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 11/2023 - 09/2023